R
RapidPulse develops minimally invasive vascular devices specifically designed for the treatment of ischemic stroke. Their technology aims to restore blood flow in occluded arteries, reducing the risk of long-term neurological damage and improving patient outcomes.
Updated 4 months ago
Funding
$25.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- RapidPulse develops minimally invasive vascular devices specifically designed for the treatment of ischemic stroke. Their technology aims to restore blood flow in occluded arteries, reducing the risk of long-term neurological damage and improving patient outcomes.